EFTA02470942.pdf

From: Richard Joslin Sent: Wednesday, March 9, 2016 10:13 PM To: Jeffrey E. Subject: RE: Artspace Fed 28% (AMT) Medicare 3.8% NYS 8.82% NYC 3.88% Total 44.5% From: Jeffrey E. [mailto:jeevacation@gmail.com] Sent: Wednesday, March 09 2016 5:11 PM To: Richard Joslin Subject: Re: Artspace were we in that bracket? On Wed, Mar 9, 2016 at 5:06 PM, Richard Joslin Estimate tax savings at 44.5% marginal rate or $433,559 From: Jeffrey E. [mailto:jeevacation@gmail.com <mailto:jeevacation@gmail.com> ] Sent: Wednesday To: Richard Joslin Subject: Re: Artspace what was the net tax benefit of doing that? wrote: On Wed, Mar 9, 2016 at 5:01 PM, Richard Joslin wrote: In 2014, LDB claimed a tax loss for Artspace of $974,378 — this was loss from operations EFTA_R1_01582275 EFTA02470942 please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailtcyjeevacation@gmail.com> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeevacation@gmail.com> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved 2 EFTA_R1_01582276 EFTA02470943